Role of nuclear cardiology in advancing cardiac surgery

Aiden Abidov, Rory Hachamovitch, Daniel S. Berman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cardiac surgeons are commonly faced with issues regarding the balance between the potential risk and the potential benefit of a surgical procedure. Nuclear cardiology procedures [myocardial perfusion SPECT (MPS) and positron emission tomography (PET)] provide the surgeon with objective information that augments standard clinical and angiographic assessments with respect to diagnosis, prognosis, and potential benefit from intervention. Development of the technology and methodology of gated MPS acquisition and interpretation allows assessment of the extent and severity of hypoperfused but viable myocardium, as well as global LVEF and LV volume measurements, diastolic function, and LV geometry. With PET, myocardial metabolism and blood flow reserve can also be measured. This chapter provides insight into the current evidence regarding settings in which nuclear cardiology procedures are helpful to the surgeon in assessment of patients having or being considered for cardiac surgery in the setting of coronary artery disease (CAD). Overall, a risk-benefit approach to MPS results is proposed, with principal focus on identifying patients at risk for major cardiac events who may benefit from a surgical procedure.

Original languageEnglish (US)
Pages (from-to)255-265
Number of pages11
JournalSeminars in Thoracic and Cardiovascular Surgery
Volume16
Issue number3
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Cardiology
Thoracic Surgery
Single-Photon Emission-Computed Tomography
Perfusion
Positron-Emission Tomography
Coronary Artery Disease
Myocardium
Technology
Surgeons

Keywords

  • Cardiac PET
  • Coronary artery disease
  • Diagnosis
  • Myocardial perfusion SPECT
  • Myocardial revascularization
  • Nuclear cardiology
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Role of nuclear cardiology in advancing cardiac surgery. / Abidov, Aiden; Hachamovitch, Rory; Berman, Daniel S.

In: Seminars in Thoracic and Cardiovascular Surgery, Vol. 16, No. 3, 09.2004, p. 255-265.

Research output: Contribution to journalArticle

Abidov, Aiden ; Hachamovitch, Rory ; Berman, Daniel S. / Role of nuclear cardiology in advancing cardiac surgery. In: Seminars in Thoracic and Cardiovascular Surgery. 2004 ; Vol. 16, No. 3. pp. 255-265.
@article{b51d60cc83e94f8ba3b3b43d4d9f8a17,
title = "Role of nuclear cardiology in advancing cardiac surgery",
abstract = "Cardiac surgeons are commonly faced with issues regarding the balance between the potential risk and the potential benefit of a surgical procedure. Nuclear cardiology procedures [myocardial perfusion SPECT (MPS) and positron emission tomography (PET)] provide the surgeon with objective information that augments standard clinical and angiographic assessments with respect to diagnosis, prognosis, and potential benefit from intervention. Development of the technology and methodology of gated MPS acquisition and interpretation allows assessment of the extent and severity of hypoperfused but viable myocardium, as well as global LVEF and LV volume measurements, diastolic function, and LV geometry. With PET, myocardial metabolism and blood flow reserve can also be measured. This chapter provides insight into the current evidence regarding settings in which nuclear cardiology procedures are helpful to the surgeon in assessment of patients having or being considered for cardiac surgery in the setting of coronary artery disease (CAD). Overall, a risk-benefit approach to MPS results is proposed, with principal focus on identifying patients at risk for major cardiac events who may benefit from a surgical procedure.",
keywords = "Cardiac PET, Coronary artery disease, Diagnosis, Myocardial perfusion SPECT, Myocardial revascularization, Nuclear cardiology, Prognosis",
author = "Aiden Abidov and Rory Hachamovitch and Berman, {Daniel S.}",
year = "2004",
month = "9",
doi = "10.1053/j.semtcvs.2004.08.010",
language = "English (US)",
volume = "16",
pages = "255--265",
journal = "Seminars in Thoracic and Cardiovascular Surgery",
issn = "1043-0679",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Role of nuclear cardiology in advancing cardiac surgery

AU - Abidov, Aiden

AU - Hachamovitch, Rory

AU - Berman, Daniel S.

PY - 2004/9

Y1 - 2004/9

N2 - Cardiac surgeons are commonly faced with issues regarding the balance between the potential risk and the potential benefit of a surgical procedure. Nuclear cardiology procedures [myocardial perfusion SPECT (MPS) and positron emission tomography (PET)] provide the surgeon with objective information that augments standard clinical and angiographic assessments with respect to diagnosis, prognosis, and potential benefit from intervention. Development of the technology and methodology of gated MPS acquisition and interpretation allows assessment of the extent and severity of hypoperfused but viable myocardium, as well as global LVEF and LV volume measurements, diastolic function, and LV geometry. With PET, myocardial metabolism and blood flow reserve can also be measured. This chapter provides insight into the current evidence regarding settings in which nuclear cardiology procedures are helpful to the surgeon in assessment of patients having or being considered for cardiac surgery in the setting of coronary artery disease (CAD). Overall, a risk-benefit approach to MPS results is proposed, with principal focus on identifying patients at risk for major cardiac events who may benefit from a surgical procedure.

AB - Cardiac surgeons are commonly faced with issues regarding the balance between the potential risk and the potential benefit of a surgical procedure. Nuclear cardiology procedures [myocardial perfusion SPECT (MPS) and positron emission tomography (PET)] provide the surgeon with objective information that augments standard clinical and angiographic assessments with respect to diagnosis, prognosis, and potential benefit from intervention. Development of the technology and methodology of gated MPS acquisition and interpretation allows assessment of the extent and severity of hypoperfused but viable myocardium, as well as global LVEF and LV volume measurements, diastolic function, and LV geometry. With PET, myocardial metabolism and blood flow reserve can also be measured. This chapter provides insight into the current evidence regarding settings in which nuclear cardiology procedures are helpful to the surgeon in assessment of patients having or being considered for cardiac surgery in the setting of coronary artery disease (CAD). Overall, a risk-benefit approach to MPS results is proposed, with principal focus on identifying patients at risk for major cardiac events who may benefit from a surgical procedure.

KW - Cardiac PET

KW - Coronary artery disease

KW - Diagnosis

KW - Myocardial perfusion SPECT

KW - Myocardial revascularization

KW - Nuclear cardiology

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=12144283535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144283535&partnerID=8YFLogxK

U2 - 10.1053/j.semtcvs.2004.08.010

DO - 10.1053/j.semtcvs.2004.08.010

M3 - Article

VL - 16

SP - 255

EP - 265

JO - Seminars in Thoracic and Cardiovascular Surgery

JF - Seminars in Thoracic and Cardiovascular Surgery

SN - 1043-0679

IS - 3

ER -